Virpax Pharmaceuticals (VRPX) Institutional Ownership → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free VRPX Stock Alerts $0.73 +0.02 (+2.82%) (As of 05/29/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Virpax Pharmaceuticals (NASDAQ:VRPX)CurrentInstitutional OwnershipPercentage32.23%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$857.57K Get VRPX Insider Trade Alerts Want to know when executives and insiders are buying or selling Virpax Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VRPX Institutional Buying and Selling by Quarter Ad Wealthpin ProAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. Virpax Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2023 Sabby Management LLC292,790$234K0.2%-26.8%2.500% 5/13/2022 Warberg Asset Management LLC17,710$39K0.0%N/A0.151% 11/17/2021 Altium Capital Management LP271,846$1.31M0.3%N/A2.320% 11/16/2021 National Asset Management Inc.18,600$90K0.0%N/A0.159% 11/2/2021 Cambridge Investment Research Advisors Inc.19,420$93K0.0%N/A0.166% 9/17/2021 Virtu Financial LLC23,625$107K0.0%N/A0.468% 8/16/2021 Sabby Management LLC154,737$704K0.1%-22.6%3.120% 8/12/2021 Saltoro Capital LP17,615$80K0.0%-34.8%0.355% 5/14/2021 HN Saltoro Capital LP27,000$127K0.0%N/A0.546% (Data available from 1/1/2016 forward) VRPX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VRPX shares? During the previous two years, the following institutional investors and hedge funds held shares of Virpax Pharmaceuticals shares: Sabby Management LLC ($234K).Learn more on VRPX's institutional investors. What percentage of Virpax Pharmaceuticals stock is owned by institutional investors? 32.23% of Virpax Pharmaceuticals stock is owned by institutional investors. Learn more on VRPX's institutional investor holdings. Which Virpax Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Virpax Pharmaceuticals stock in the last 24 months: Sabby Management LLC ($107.21K). How much institutional selling is happening at Virpax Pharmaceuticals? Institutional investors have sold a total of 107,210 shares in the last 24 months. This volume of shares sold represents approximately $857.57K in transactions. Related Companies: SXTP Major Shareholders XCUR Major Shareholders SEEL Major Shareholders APVO Major Shareholders ARAV Major Shareholders CYCC Major Shareholders QNRX Major Shareholders REVB Major Shareholders AGRX Major Shareholders CYTO Major Shareholders This page (NASDAQ:VRPX) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTradeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyBUY ALERT: Tiny tech play partners with US governmentStansberry ResearchGold Set to EXPLODE!Gold Safe Exchange[Urgent!] Generational Wealth GameplanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.